Previous Article | Next Article 
Infection and Immunity, July 1999, p. 3329-3333, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Experimental Lyme Arthritis in the Absence of
Interleukin-4 or Gamma Interferon
Charles R.
Brown,1 and
Steven L.
Reiner1,2,*
Department of Medicine and Gwen Knapp Center
for Lupus and Immunology Research, Committee on
Immunology,1 and Committee on
Developmental Biology,2 University of Chicago,
Chicago, Illinois 60637
Received 4 February 1999/Returned for modification 26 March
1999/Accepted 15 April 1999
 |
ABSTRACT |
Genetic resistance and susceptibility to experimental Lyme
arthritis have been linked with the production of interleukin-4 (IL-4)
or gamma interferon (IFN-
), respectively. To determine the absolute
requirement for these cytokines in disease outcome, we compared
arthritis development in wild-type, IL-4-deficient (IL-4°), and
IFN-
-deficient (IFN-
°) mice. While susceptible C3H mice
developed swelling of ankle joints during the second week of infection,
this swelling was exacerbated in C3H IFN-
° mice. Their arthritis
severity scores at day 21, however, were similar. Resolution of
arthritis was also similar between C3H and C3H IFN-
° mice.
Arthritis-resistant DBA mice did not develop ankle swelling during the
experimental period. There were no differences in ankle swelling or
arthritis severity scores between control DBA mice and DBA IL-4° mice
at any of the time points tested. While the presence of spirochetes in
various tissues was similar among all strains at day 21, DBA IL-4°
mice had a higher presence of spirochetes in blood, heart, and spleen
than the DBA, C3H, and C3H IFN-
° mice did at day 60. DBA IL-4°
mice also had impaired ability to produce Borrelia-specific
antibody responses, especially immunoglobulin G1. Thus, while IFN-
and IL-4 are not absolutely required for arthritis susceptibility or
resistance, the production of IL-4 does appear to play an important
role in Borrelia-specific antibody production and
spirochete clearance.
 |
INTRODUCTION |
Experimental Lyme borreliosis is
caused by the infection of inbred strains of mice with the spirochete
Borrelia burgdorferi. While all mouse strains are
susceptible to infection with B. burgdorferi, only certain strains develop severe arthritis (2). C3H/HeJ (C3H) mice will develop severe arthritis when infected with as few as
200 spirochetes (20). In contrast, C57BL/6J (B6) or DBA/2J (DBA) mice are resistant to arthritis development even when infected with 106 spirochetes (6, 20). BALB/c mice
represent an intermediate-responding strain, which are resistant to
arthritis development when challenged with low numbers of spirochetes,
but develop arthritis of increasing severity as the infectious dosage
is increased (20). Clearly, host factors play critical roles
in determining the extent of arthritis following infection with
B. burgdorferi.
The development of arthritis following experimental inoculation of mice
with B. burgdorferi correlates with T-cell subset development (17, 21). T cells from arthritis-resistant
BALB/c mice produce interleukin-4 (IL-4) and develop a Th2 phenotype following infection with B. burgdorferi (17,
21). In contrast, T cells from arthritis-susceptible C3H mice
produce gamma interferon (IFN-
) and develop a Th1 phenotype
following infection with B. burgdorferi (17,
21). Treatment of BALB/c mice with antibody to IL-4 increased the
severity of arthritis, while treatment of C3H mice with either antibody
to IFN-
or recombinant IL-4 reduced arthritis development (17,
18, 21). These results suggested that T-cell cytokines might be
important mediators of resistance and susceptibility to Lyme
arthritis development. Recent reports, however, have indicated
that these cytokines may not be absolutely required for disease
modulation. Signaling through B7-1 and B7-2 has been shown to influence
arthritis severity in susceptible C3H mice (1). Blocking of
B7-CD28 interactions in BALB/c mice, however, decreased IL-4 production
and increased IFN-
levels, but did not alter arthritis development
(27). The timing of IL-4 production also suggests it may act
to resolve arthritis inflammation, not prevent it (15).
Similarly, we have recently shown that depletion of NK cells in C3H
mice ablates their early IFN-
production, but does not alter
arthritis development (7). Thus the absolute roles of IL-4
and IFN-
in resistance and susceptibility to Lyme arthritis
development are unclear.
To assess the requirement for IL-4 and IFN-
in resistance or
susceptibility to experimental Lyme arthritis, we infected DBA IL-4-deficient (DBA IL-4°) or C3H IFN-
-deficient (C3H IFN-
°) mice and monitored arthritis development and resolution. Our results show that IFN-
deficiency has little effect on either arthritis development and resolution or on mounting an efficient immune response
against B. burgdorferi. While IL-4 deficiency in DBA mice had little effect on their resistance to arthritis development, they were unable to mount an effective antibody response to
B. burgdorferi and were unable to efficiently clear
spirochetes from their tissues.
 |
MATERIALS AND METHODS |
Mice.
All mice were females between 4 and 6 weeks of age at
the time of infection. DBA/2J (DBA) mice were purchased from The
Jackson Laboratory (Bar Harbor, Maine). DBA IL-4° mice were generated from BALB/c IL-4° mice (a generous gift from Horst Bluthmann [F. Hoffman-La Roche AG]) by backcrossing to DBA mice for 5 generations. C3H IFN-
° mice were generated from C57BL/6 × 129 IFN-
°
mice (a kind gift from Genentech) by backcrossing to C3H for 5 generations. Littermate C3H IFN-
+/+ or C3H
IFN-
+/
were used as control animals.
Bacteria and infections.
The N40 strain of B. burgdorferi was kindly provided by Steven Barthold (Yale
University, New Haven, Conn.), and spirochetes were recovered from
samples frozen in aliquots as described previously (6). Mice
were inoculated in both hind footpads with 5 × 105
B. burgdorferi organisms in 50 µl of
Barbour-Stoenner-Kelley II medium (Sigma Chemical Co., St. Louis, Mo.).
Tibiotarsal joints were measured weekly with a metric caliper
(Ralmike's Tool-A-Rama, South Plainfield, N.J.) through the thickest
anteroposterior diameter of the ankle. Mice were sacrificed on day 21 or 60 following infection. Blood, heart, spleen, urinary bladder, skin,
and ankles were aseptically collected and cultured at 32°C for 14 days in Barbour-Stoenner-Kelley media. Cultures were read by placing 10 µl of supernatant on a microscope slide under a 22 by 22 mm coverslip
and examining 20 high-powered fields by dark-field microscopy. In some
experiments, one ankle from each mouse was frozen for PCR analysis. In
other experiments, one ankle from each mouse was formalin fixed,
embedded in paraffin, stained with hematoxylin and eosin, and blindly
evaluated for arthritis severity on a scale of 0 to 3 (3).
Grade 0 represents no inflammation, grades 1 and 2 represent mild to
moderate inflammation, and grade 3 represents severe inflammation.
Arthritis in histological samples was characterized by neutrophil and
monocyte infiltration into the joints, tendons, and ligament sheaths;
hyperplasia and hypertrophy of the synovium; and fibrin exudates. The
extent of the observed inflammatory changes provided the basis for the
arthritis severity scores.
PCR analysis.
To extract DNA from ankles, samples were first
incubated in 0.5 ml of 1% collagenase overnight at 37°C. Tissue was
then digested by incubation in 0.25 ml of 3× sodium dodecyl sulfate
(SDS)-Tris lysis buffer (0.3 mg of proteinase K per ml in 600 mM
NaCl-20 mM Tris-HCl [pH 8.0]-150 mM EDTA-0.6% SDS) for 16 h
at 55°C. DNA was extracted with phenol-chloroform and precipitated
with ethanol. The sample DNA was resuspended in 200 µl of Tris-EDTA
buffer. DNA samples from uninfected mice were tested as negative
controls. Competitive PCR was performed as described previously
(6) by using a constant amount of the BC3 polycompetitor and
approximately 150 ng of sample DNA. The BC3 polycompetitor consists of
a linear DNA molecule which contains modified portions of the
ospA and flagellin genes of B. burgdorferi
and a modified portion of the promoter region of the single-copy
mammalian IL-4 gene (IL-4pr) (6). The presence of
B. burgdorferi ospA in sample DNA was detected with the
following primers: ospA 5' primer
TCTTGAAGGAACTTTAACTGCTG and ospA 3' primer
CAAGTTTTGTAATTTCAACTGCTGA. PCR mixtures were denatured for
60 s at 94°C, followed by cycles of denaturation at 94°C for
60 s, annealing at 60°C for 60 s, and extension at 72°C
for 90 s for 35 cycles. Amplified products were visualized on a
2.5% agarose gel.
ELISA for IgG.
For the enzyme-linked immunosorbent assay
(ELISA) for immunoglobulin G (IgG), mice were bled from the
retro-orbital plexus prior to infection and then every 10th day for the
remainder of the experiment. Serum was collected and stored at 4°C
until analyzed. Briefly, 96-well Immulon plates were coated with 40 µl of sonicated B. burgdorferi antigen (30 µg/ml)
overnight at 4°C. The wells were then blocked with 3% bovine serum
albumin (BSA) in phosphate-buffered saline (PBS) for 2 h at room
temperature. Dilutions of mouse serum (1:100 in 3% BSA) were added to
replicate plates and incubated for 2 h at room temperature.
Samples were then incubated with alkaline phosphatase-conjugated rat
anti-mouse antibodies to IgG1, IgG2a, IgG2b, and IgG3 (all from
PharMingen, San Diego, Calif.) or IgG (heavy plus light chains)
(Jackson ImmunoResearch, West Grove, Pa.), diluted 1:1,000 in 3% BSA
in PBS, and incubated at room temperature for 45 min. Plates were
developed with Sigma 104 reagent (Sigma Chemical Co., St. Louis, Mo.)
and read at 405 nm on a spectrophotometer.
Statistics.
Data were analyzed by Student's t
test for single comparisons or Tukey's test for multiple comparisons.
Critical values for statistical significance were set at
= 0.05.
 |
RESULTS |
Development of arthritis.
To determine the absolute
requirement for the production of IL-4 and IFN-
on disease
resistance or susceptibility, we infected C3H IFN-
° and DBA
IL-4° mice along with wild-type controls and observed arthritis
development for 21 or 60 days. C3H and C3H IFN-
° mice developed
severe swelling of their tibiotarsal joints by 14 days following
inoculation of 5 × 105 B. burgdorferi
organisms into their hind footpads (Fig.
1). The footpad route of infection was
used to deliver the organisms near the tibiotarsal joints and to
control for differences in spirochete dissemination between mice of
different strains and with immunological deficiency. DBA and DBA
IL-4° mice did not develop any ankle swelling during the experimental
period. Ankle diameters of C3H and C3H IFN-
° mice were
significantly larger than those of DBA and DBA IL-4° mice on days 14 and 21 of infection (P < 0.001). C3H IFN-
° mice
had consistently greater ankle swelling than wild-type C3H mice during
the acute phase of arthritis development (P < 0.01). Arthritis resolution, however, was similar for C3H and C3H IFN-
° mice, and ankle swelling was completely resolved by day 60 in both
strains (data not shown). There were no differences in ankle swelling
between DBA and DBA IL-4° mice during either arthritis development
(Fig. 1) or resolution (data not shown). Similar results were seen with
BALB/c and BALB/c IL-4° mice (data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Ankle swelling following infection of IL-4° and
IFN- ° mice with B. burgdorferi. Mice (three to
five per group) were 4 to 6 weeks old at the time of infection and were
inoculated in the hind footpads. Panels are representative of five
separate experiments. Open symbols represent wild-type animals, and
solid symbols represent cytokine-deficient animals. Ankle curves are
shown for C3H (squares) and DBA (circles) mice. Error bars represent
standard deviation. Asterisks indicate significant differences in ankle
swelling between C3H IFN- ° and C3H mouse strains (P < 0.01).
|
|
Arthritis development was also examined histologically, since it does
not always correlate with ankle diameter. Hematoxylin-and-eosin-stained sections of ankle tissue were scored for arthritis severity in a
blinded manner as previously described (3). A severity score of 0 represents no inflammation, while a score of 3 represents severe
arthritis. At day 21, severity scores were significantly higher for C3H
and C3H IFN-
° mice than for the DBA and DBA IL-4° mice (Table 1;
P < 0.001). There were no differences, however, in
severity scores between C3H and C3H IFN-
° mice. Arthritis severity
scores of DBA IL-4° mice tended to be slightly lower than those of
wild-type DBA mice, but these differences were not statistically
significant. At day 60, arthritis severity scores were similar between
all strains tested (Table 1). However, while the scores had decreased
for all other strains, the arthritis severity scores of DBA IL-4°
mice were nearly identical to those from day 21. This suggested that
spirochete clearance might not be as efficient in these mice.
Spirochete burden in tissues.
The effect of deficiency in
IFN-
or IL-4 might not only alter arthritis development, but might
also affect the ability of mice to mount effective immune responses
against B. burgdorferi. To determine if there were
differences in spirochetal burdens in tissues, we sacrificed
knockout and wild-type mice at these two time points,
cultured various tissues, and scored them 14 days later for the
presence of spirochetes. At day 21, during the acute phase of
infection, few differences can be seen between mouse strains in the
presence of B. burgdorferi spirochetes in the various
tissues (Table 1). Cultures from tissues
with high spirochete tropism
urinary bladder, skin (ear punches), and
ankles
were almost uniformly positive. The presence of spirochetes in
other tissues was more variable, but few differences between wild-type and knockout mice could be seen (Table 1). At day 60, however, the DBA
IL-4° mice still had high numbers of positive cultures in blood,
heart, and spleen samples, while the other mouse strains had mostly
cleared these tissues (Table 1). To compare the absolute numbers of
spirochetes, we used competitive PCR of ankle joints. Figure
2 shows the comparative levels of
spirochete DNA in ankles from mice infected for 60 days. These results
show that, although there was some variability between strains and
among mice of the same strain, the DBA IL-4° mice did not have
greatly increased levels of spirochetes within their ankle tissues.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Isolation of B. burgdorferi from selected
tissues and arthritis development in ankles of control and cytokine
knockout micea
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Competitive PCR amplification of ospA and
IL-4pr genes from ankles of C3H, C3H IFN- °, DBA, and DBA IL-4°
mice. The control lane contains DNA from an uninfected mouse. The upper
bands in each lane are the BC3 competitor amplification products, and
the lower bands are wild-type DNA PCR products. Each lane represents
data from an individual mouse. Sample DNA levels were equalized by
using primers for the single-copy mammalian IL-4pr gene. Spirochete DNA
was amplified by using primers for ospA. The amount of BC3
competitor spiked into each sample was 0.25 pg.
|
|
Borrelia-specific antibody responses.
Resolution
of Lyme arthritis and spirochetal clearance has been mainly attributed
to the production of antibody (4). T cells may be involved,
however, especially through the production of cytokines which promote
antibody production. Th1 cytokines promote increased levels of IgG2a,
while Th2 cytokines promote increased levels of IgG1 and IgG2b. To
determine if the IL-4 or IFN-
deficiency caused any changes in
Borrelia-specific antibody responses, control and knockout
mice were bled every 10 days during the infection and antibody
responses were measured by ELISA. The production of total
Borrelia-specific IgG over the course of the experiment is
shown in Fig. 3A. While C3H, C3H
IFN-
°, and DBA mice made increasing amounts of
anti-Borrelia IgG during the infection, the DBA IL-4° mice
had depressed antibody responses. As expected, C3H IFN-
° mice had
depressed levels of IgG2a compared with wild-type C3H mice and produced
levels similar to that of mice on the susceptible DBA background (Fig.
3B). While levels of IgG2b were similar between all mice tested, DBA
IL-4° mice had greatly depressed production of IgG1. Since IgG1 makes
up approximately 80% of the IgG antibody levels in mice, this
deficiency could explain the low total IgG levels seen in the DBA
IL-4° mice (Fig. 3A). Thus, IL-4 may play an important role in
resistant mouse strains by promoting Borrelia-specific IgG1
production and contributing to efficient spirochetal clearance.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
IgG in B. burgdorferi-infected control,
IFN- °, and IL-4° mice. Antibody titers in sera were measured by
ELISA for total IgG over the course of the infection (A) and for IgG
subsets on day 60 (B).
|
|
 |
DISCUSSION |
Resistance or susceptibility to experimental Lyme arthritis
development has been correlated with the production of IL-4 or IFN-
,
respectively, and T helper cell subset development (17, 21).
Mice with a Th2 phenotype were resistant, and mice with a Th1 phenotype
were susceptible. Moreover, treatment of mice with antibody to IL-4 or
IFN-
could attenuate or exacerbate arthritis development (17,
18, 21). These studies supported the hypothesis that genetic
resistance and susceptibility to Lyme arthritis were mediated by T
helper cell subset phenotypes. Studies with humans also supported this
view; for example, peripheral blood mononuclear cells from patients
with active disease produced more IFN-
and less IL-4 than those from
controls (23). Similarly, the Th1/Th2 ratio was highest in
patients with active disease (13), and high numbers of T
cells with the Th1 phenotype can be isolated from these types of
patients (30). The absolute requirement of these cytokines
for resistance or susceptibility, however, has been challenged
recently. In the present study, we demonstrated that IFN-
was not
absolutely required for arthritis development or resolution or for the
generation of an effective immune response. Likewise, IL-4 was also not
absolutely required for resistance to arthritis development, but may
play an important role in stimulating an effective immune response.
Likewise, IL-4 was also not absolutely required for resistance to
arthritis development, but may play an important role in stimulating an
effective immune response against B. burgdorferi.
The production of IL-4 is an important mediator of T-cell help to B
cells in the production of antibodies to T-dependent antigens. B. burgdorferi-specific humoral responses are thought
to be the primary mediators of arthritis resolution and bacterial
clearance (4). SCID mice can be protected from arthritis by
the transfer of presensitized spleen cells and partially by B cells,
but not by T cells alone (26). Similarly, transfer of immune
sera, but not T cells, will induce arthritis resolution in
B. burgdorferi-infected SCID mice (4, 5).
Recent studies have shown that arthritis-protective antibodies can
arise without the need for T-cell help. For example, protective
antibodies arise and arthritis resolves in CD40 ligand-deficient mice
and also in mice deficient in major histocompatibility complex class II
and CD4+ T cells (10). Also, a single exposure
of mice to B. burgdorferi elicits IgG characteristic of
secondary immune responses without the production of IL-4 by immune T
cells (12). In contrast, other studies using intradermal
infection of mice with B. burgdorferi have suggested
that CD4+ T cells and T-dependent antibody responses may
play a role in protection against arthritis development, since
depletion of CD4+ T cells results in an increase in ankle
swelling (16), and passive transfer of CD4+ Th2
T cell lines or clones can also protect against pathology (24,
25). In the present study, footpad inoculation of DBA IL-4°
mice resulted in a significant decrease in their B. burgdorferi-specific total IgG production. Most of this decrease
was of the IgG1 subtype. While the IL-4 deficiency appeared to have no
effect on the resistance of these mice to arthritis development, it did
appear to have an effect on arthritis resolution and spirochetal
clearance in certain tissues. Arthritis severity scores decreased in
the other mouse strains from day 21 to day 60. In the DBA IL-4° mice,
however, there was no decrease in the arthritis severity scores,
suggesting a defect in arthritis resolution, possibly mediated by a
T-dependent antigen. Spirochetes appeared to be as efficiently cleared
from ankles in the DBA IL-4° mice as in the other strains of mice. However, clearance from blood, hearts, and spleens appeared to be less
efficient. This is similar to the effect reported by others using the
intradermal infection model that CD4+ T cells might be
required for resolution of carditis (10).
In conclusion, these results demonstrate that IFN-
is not required
for arthritis development or resolution, nor is it needed for efficient
control of spirochetal burdens. In contrast, while IL-4 is not required
for resistance to arthritis development, it does appear to play a role
in arthritis resolution and spirochetal clearance from specific
tissues, possibly through B-cell help and production of T-dependent
antibodies. While it is clear that these cytokines are not required for
genetic resistance or susceptibility to experimental Lyme arthritis
development, other studies have shown that one must use caution in
interpreting results obtained with knockout mice. For example, IL-4 is
considered to be crucial for the development of Th2 cells and the
susceptibility of BALB/c mice to infection with Leishmania
major (14). Despite the absence of this critical
cytokine, BALB/c IL-4° mice remained susceptible to L. major infection (22). Similarly in experimental
autoimmune encephalomyelitis, which is mediated by Th1 cells,
immunization of IFN-
° mice with the dominant autoantigen, myelin
basic protein, revealed that IFN-
was not required for the induction
or clinical course of experimental autoimmune encephalomyelitis
(9, 31). Clues to the complexity of these mechanisms have
come from studies of the host-parasite relationship between mice and
gastrointestinal nematode parasites. IL-4 has a central role in host
defense and worm expulsion (11). Infection of IL-4° mice
with either Heligmosomoides polygyrus or Trichuris
muris results in chronic infection and prevents worm expulsion
(8, 28). This is not the case, however, with the
murine-adapted strain of the gastrointestinal nematode parasite
Nippostrongylus brasiliensis (19).
Infection of BALB/c IL-4° mice with N. brasiliensis results in normal immunity and worm expulsion. This
has recently been shown to be due to the ability of IL-13 to induce
Stat6 activation through the IL-4 receptor
chain, which results in
parasite expulsion (29). Thus, the redundancy of cytokines
may explain the discrepancies between the present study and those using
antibody treatment of mice to modulate arthritis development. Whatever
the mechanism, however, it is clear that IL-4 is not required for
resistance and IFN-
is not required for susceptibility to
experimental Lyme arthritis.
 |
ACKNOWLEDGMENTS |
We thank Jennifer Bird and Nancy Reilly for technical assistance
and Horst Bluthmann (F. Hoffmann-La Roche AG) and Genentech for
supplying the knockout mice.
This work was supported by the NIH (AR 44042) and by the Burroughs
Wellcome Fund.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Gwen Knapp
Center for Lupus and Immunology Research, University of Chicago, 924 E. 57th St., R422, Chicago, IL 60637. Phone: (773) 702-4730. Fax: (773)
702-1576. E-mail: sreiner{at}midway.uchicago.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Anguita, J.,
R. Roth,
S. Samanta,
R. J. Gee,
S. W. Barthold,
M. Mamula, and E. Fikrig.
1997.
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
Infect. Immun.
65:3037-3041[Abstract].
|
| 2.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. O. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 3.
|
Barthold, S. W.,
C. L. Sidman, and A. L. Smith.
1992.
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg.
47:605-613.
|
| 4.
|
Barthold, S. W.,
M. de Souza, and S. Feng.
1996.
Serum-mediated resolution of Lyme arthritis in mice.
Lab. Investig.
74:57-67[Medline].
|
| 5.
|
Barthold, S. W.,
S. Feng,
L. K. Bockenstedt,
E. Fikrig, and K. Feen.
1997.
Protective and arthritis-resolving activity in serum of mice actively infected with Borrelia burgdorferi.
Clin. Infect. Dis.
25:S9-S17.
|
| 6.
|
Brown, C. R., and S. L. Reiner.
1998.
Clearance of Borrelia burgdorferi may not be required for resistance to experimental Lyme arthritis.
Infect. Immun.
66:2065-2071[Abstract/Free Full Text].
|
| 7.
|
Brown, C. R., and S. L. Reiner.
1998.
Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.
Infect. Immun.
66:5208-5214[Abstract/Free Full Text].
|
| 8.
|
Else, K. J.,
F. D. Finkelman,
C. R. Maliszewski, and R. K. Grencis.
1994.
Cytokine mediated regulation of chronic intestinal helminth infection.
J. Exp. Med.
179:347-351[Abstract/Free Full Text].
|
| 9.
|
Ferber, I. A.,
S. Brocke,
C. Taylor-Edwards,
W. Ridgway,
C. Dinisco,
L. Steinman,
D. Dalton, and C. G. Fathman.
1996.
Mice with a disrupted IFN- gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
J. Immunol.
156:5-7[Abstract].
|
| 10.
|
Fikrig, E.,
S. W. Barthold,
M. Chen,
C.-H. Chang, and R. A. Flavell.
1997.
Protective antibodies develop, and murine arthritis regresses in the absence of MHC class II and CD4+ T cells.
J. Immunol.
159:5682-5686[Abstract].
|
| 11.
|
Finkelman, F. D.,
T. Shea-Donohue,
J. Goldhill,
C. A. Sullivan,
S. C. Morris,
K. B. Madden,
W. C. Gause, and J. F. Urban, Jr.
1997.
Cytokine regulation of host defense against parasite gastrointestinal helminths: lessons from studies with rodent models.
Annu. Rev. Immunol.
15:505-533[Medline].
|
| 12.
|
Frey, A. B., and T. D. Rao.
1995.
Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells.
Infect. Immun.
63:2596-2603[Abstract].
|
| 13.
|
Gross, D. M.,
A. C. Steere, and B. T. Huber.
1998.
T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis.
J. Immunol.
160:1022-1028[Abstract/Free Full Text].
|
| 14.
|
Heinzel, F. P.,
M. D. Sadick,
B. J. Holaday,
R. L. Coffman, and R. M. Locksley.
1989.
Reciprocal expression of interferon gamma or IL4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets.
J. Exp. Med.
169:59-72[Abstract/Free Full Text].
|
| 15.
|
Kang, I.,
S. W. Barthold,
D. H. Persing, and L. K. Bockenstedt.
1997.
T-helper-cell cytokines in the early evolution of murine Lyme arthritis.
Infect. Immun.
65:3107-3111[Abstract].
|
| 16.
|
Keane-Myers, A., and S. P. Nickell.
1995.
T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
154:1770-1776[Abstract].
|
| 17.
|
Keane-Myers, A., and S. P. Nickell.
1995.
Role of IL-4 and IFN- in modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
155:2020-2028[Abstract].
|
| 18.
|
Keane-Myers, A.,
C. R. Maliszewski,
F. D. Finkelman, and S. P. Nickell.
1996.
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
J. Immunol.
156:2488-2494[Abstract].
|
| 19.
|
Kopf, M.,
G. Le Gros,
M. Bachman,
M. D. Lamers,
H. Bluthmann, and G. Kohler.
1993.
Disruption of the murine IL-4 gene blocks Th2 cytokine responses.
Nature
362:245-248[Medline].
|
| 20.
|
Ma, Y.,
K. P. Seiler,
E. J. Eichwald,
J. H. Weis,
C. Teuscher, and J. J. Weis.
1998.
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
Infect. Immun.
66:161-168[Abstract/Free Full Text].
|
| 21.
|
Matyniak, J., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 22.
|
Noben-Trauth, N.,
P. Kropf, and I. Muller.
1996.
Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
Science
271:987-990[Abstract].
|
| 23.
|
Oksi, J.,
J. Savolainen,
J. Pène,
J. Bousquet,
P. Laippala, and M. K. Viljanen.
1996.
Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis.
Infect. Immun.
64:3620-3623[Abstract].
|
| 24.
|
Rao, T. D.,
A. Fischer, and A. B. Frey.
1994.
CD4+ Th2 cells elicited by immunization confer protective immunity to experimental Borrelia burgdorferi infection.
Ann. N. Y. Acad. Sci.
730:364-366[Medline].
|
| 25.
|
Rao, T. D., and A. B. Frey.
1995.
Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone.
Cell. Immunol.
162:225-234[Medline].
|
| 26.
|
Schaible, U. E.,
R. Wallich,
M. D. Kramer,
G. Nerz,
T. Stehle,
C. Museteanu, and M. M. Simon.
1994.
Protection against Borrelia burgdorferi infection in scid mice is conferred by presensitized spleen cells and partially by B but not T cells alone.
Int. Immunol.
6:671-681[Abstract/Free Full Text].
|
| 27.
|
Shanafelt, M.-C.,
I. Kang,
S. W. Barthold, and L. K. Bockenstedt.
1998.
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Infect. Immun.
66:266-271[Abstract/Free Full Text].
|
| 28.
|
Urban, J. F., Jr.,
I. M. Katona,
W. E. Paul, and F. D. Finkelman.
1991.
Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice.
Proc. Natl. Acad. Sci. USA
88:5513-5517[Abstract/Free Full Text].
|
| 29.
|
Urban, J. F., Jr.,
N. Noben-Trauth,
D. D. Donaldson,
K. B. Madden,
S. C. Morris,
M. Collins, and F. D. Finkelman.
1998.
IL-13, IL-4R , and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis.
Immunity
8:255-264[Medline].
|
| 30.
|
Yssel, H.,
M. C. Shanafelt,
C. Soderberg,
P. V. Schneider,
J. Anzola, and G. Peltz.
1991.
Borrelia burgdorferi activates T helper type 1-like T cell subset in Lyme arthritis.
J. Exp. Med.
174:593-601[Abstract/Free Full Text].
|
| 31.
|
Zamvil, S. S.,
D. J. Mitchell,
A. C. Moore,
A. J. Schwarz,
W. Stiefel,
P. A. Nelson,
J. B. Rothbard, and L. Steinman.
1987.
T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
J. Immunol.
139:1075-1079[Abstract].
|
Infection and Immunity, July 1999, p. 3329-3333, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kotloski, N. J., Nardelli, D. T., Peterson, S. H., Torrealba, J. R., Warner, T. F., Callister, S. M., Schell, R. F.
(2008). Interleukin-23 Is Required for Development of Arthritis in Mice Vaccinated and Challenged with Borrelia Species. CVI
15: 1199-1207
[Abstract]
[Full Text]
-
Nardelli, D. T., Callister, S. M., Schell, R. F.
(2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI
15: 21-34
[Full Text]
-
Iliopoulou, B. P., Alroy, J., Huber, B. T.
(2007). CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis. J. Immunol.
179: 8076-8082
[Abstract]
[Full Text]
-
Moore, M. W., Cruz, A. R., LaVake, C. J., Marzo, A. L., Eggers, C. H., Salazar, J. C., Radolf, J. D.
(2007). Phagocytosis of Borrelia burgdorferi and Treponema pallidum Potentiates Innate Immune Activation and Induces Gamma Interferon Production. Infect. Immun.
75: 2046-2062
[Abstract]
[Full Text]
-
Dame, T. M., Orenzoff, B. L., Palmer, L. E., Furie, M. B.
(2007). IFN-{gamma} Alters the Response of Borrelia burgdorferi-Activated Endothelium to Favor Chronic Inflammation. J. Immunol.
178: 1172-1179
[Abstract]
[Full Text]
-
Crandall, H., Dunn, D. M., Ma, Y., Wooten, R. M., Zachary, J. F., Weis, J. H., Weiss, R. B., Weis, J. J.
(2006). Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis. J. Immunol.
177: 7930-7942
[Abstract]
[Full Text]
-
Lazarus, J. J., Meadows, M. J., Lintner, R. E., Wooten, R. M.
(2006). IL-10 Deficiency Promotes Increased Borrelia burgdorferi Clearance Predominantly through Enhanced Innate Immune Responses. J. Immunol.
177: 7076-7085
[Abstract]
[Full Text]
-
Hedrick, M. N., Olson, C. M. Jr., Conze, D. B., Bates, T. C., Rincon, M., Anguita, J.
(2006). Control of Borrelia burgdorferi-Specific CD4+-T-Cell Effector Function by Interleukin-12- and T-Cell Receptor-Induced p38 Mitogen-Activated Protein Kinase Activity.. Infect. Immun.
74: 5713-5717
[Abstract]
[Full Text]
-
Widhe, M., Skogman, B. H., Jarefors, S., Eknefelt, M., Enestrom, G., Nordwall, M., Ekerfelt, C., Croner, S., Bergstrom, S., Forsberg, P., Ernerudh, J.
(2005). Up-regulation of Borrelia-specific IL-4- and IFN-{gamma}-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol
17: 1283-1291
[Abstract]
[Full Text]
-
Glasner, J., Blum, H., Wehner, V., Stilz, H. U., Humphries, J. D., Curley, G. P., Mould, A. P., Humphries, M. J., Hallmann, R., Rollinghoff, M., Gessner, A.
(2005). A Small Molecule {alpha}4{beta}1 Antagonist Prevents Development of Murine Lyme Arthritis without Affecting Protective Immunity. J. Immunol.
175: 4724-4734
[Abstract]
[Full Text]
-
Wang, X., Ma, Y., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2005). Relative Contributions of Innate and Acquired Host Responses to Bacterial Control and Arthritis Development in Lyme Disease. Infect. Immun.
73: 657-660
[Abstract]
[Full Text]
-
Nardelli, D. T., Burchill, M. A., England, D. M., Torrealba, J., Callister, S. M., Schell, R. F.
(2004). Association of CD4+ CD25+ T Cells with Prevention of Severe Destructive Arthritis in Borrelia burgdorferi-Vaccinated and Challenged Gamma Interferon-Deficient Mice Treated with Anti-Interleukin-17 Antibody. CVI
11: 1075-1084
[Abstract]
[Full Text]
-
Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F.
(2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI
11: 35-41
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2003). Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2. J. Immunol.
171: 893-901
[Abstract]
[Full Text]
-
Burchill, M. A., Nardelli, D. T., England, D. M., DeCoster, D. J., Christopherson, J. A., Callister, S. M., Schell, R. F.
(2003). Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi. Infect. Immun.
71: 3437-3442
[Abstract]
[Full Text]
-
Bockenstedt, L. K., Shanafelt, M.-C., Belperron, A., Mao, J., Barthold, S. W.
(2003). Humoral Immunity Reflects Altered T Helper Cell Bias in Borrelia burgdorferi-Infected {gamma}{delta} T-Cell-Deficient Mice. Infect. Immun.
71: 2938-2940
[Abstract]
[Full Text]
-
Christopherson, J. A., Munson, E. L., England, D. M., Croke, C. L., Remington, M. C., Molitor, M. L., DeCoster, D. J., Callister, S. M., Schell, R. F.
(2003). Destructive Arthritis in Vaccinated Interferon Gamma-Deficient Mice Challenged with Borrelia burgdorferi: Modulation by Tumor Necrosis Factor Alpha. CVI
10: 44-52
[Abstract]
[Full Text]
-
Hefty, P. S., Brooks, C. S., Jett, A. M., White, G. L., Wikel, S. K., Kennedy, R. C., Akins, D. R.
(2002). OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients. J. Clin. Microbiol.
40: 4256-4265
[Abstract]
[Full Text]
-
Anguita, J., Barthold, S. W., Persinski, R., Hedrick, M. N., Huy, C. A., Davis, R. J., Flavell, R. A., Fikrig, E.
(2002). Murine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity. J. Immunol.
168: 6352-6357
[Abstract]
[Full Text]
-
Bockenstedt, L. K., Kang, I., Chang, C., Persing, D., Hayday, A., Barthold, S. W.
(2001). CD4+ T Helper 1 Cells Facilitate Regression of Murine Lyme Carditis. Infect. Immun.
69: 5264-5269
[Abstract]
[Full Text]
-
Glickstein, L., Edelstein, M., Dong, J. Z.
(2001). Gamma Interferon Is Not Required for Arthritis Resistance in the Murine Lyme Disease Model. Infect. Immun.
69: 3737-3743
[Abstract]
[Full Text]
-
Thomas, V., Anguita, J., Barthold, S. W., Fikrig, E.
(2001). Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis. Infect. Immun.
69: 3359-3371
[Abstract]
[Full Text]
-
Gergel, E. I., Furie, M. B.
(2001). Activation of Endothelium by Borrelia burgdorferi In Vitro Enhances Transmigration of Specific Subsets of T Lymphocytes. Infect. Immun.
69: 2190-2197
[Abstract]
[Full Text]
-
Pachner, A. R., Amemiya, K., Bartlett, M., Schaefer, H., Reddy, K., Zhang, W.-F.
(2001). Lyme Borreliosis in Rhesus Macaques: Effects of Corticosteroids on Spirochetal Load and Isotype Switching of Anti-Borrelia burgdorferi Antibody. CVI
8: 225-232
[Abstract]
[Full Text]
-
Ganapamo, F., Dennis, V. A., Philipp, M. T.
(2000). Early Induction of Gamma Interferon and Interleukin-10 Production in Draining Lymph Nodes from Mice Infected with Borrelia burgdorferi. Infect. Immun.
68: 7162-7165
[Abstract]
[Full Text]
-
Potter, M. R., Noben-Trauth, N., Weis, J. H., Teuscher, C., Weis, J. J.
(2000). Interleukin-4 (IL-4) and IL-13 Signaling Pathways Do Not Regulate Borrelia burgdorferi-Induced Arthritis in Mice: IgG1 Is Not Required for Host Control of Tissue Spirochetes. Infect. Immun.
68: 5603-5609
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(2000). Bone-Marrow Chimeras Reveal Hemopoietic and Nonhemopoietic Control of Resistance to Experimental Lyme Arthritis. J. Immunol.
165: 1446-1452
[Abstract]
[Full Text]